These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux. Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546 [TBL] [Abstract][Full Text] [Related]
6. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease? Zhang W; Wang DH Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663 [TBL] [Abstract][Full Text] [Related]
7. Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Kumble S; Omary MB; Fajardo LF; Triadafilopoulos G Int J Cancer; 1996 Mar; 66(1):48-54. PubMed ID: 8608965 [TBL] [Abstract][Full Text] [Related]
8. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia? Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828 [TBL] [Abstract][Full Text] [Related]
9. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. Chen X; Qin R; Liu B; Ma Y; Su Y; Yang CS; Glickman JN; Odze RD; Shaheen NJ BMC Gastroenterol; 2008 Jan; 8():1. PubMed ID: 18190713 [TBL] [Abstract][Full Text] [Related]
11. P63 Deficiency and CDX2 Overexpression Lead to Barrett's-Like Metaplasia in Mouse Esophageal Epithelium. Fang Y; Li W; Chen X Dig Dis Sci; 2021 Dec; 66(12):4263-4273. PubMed ID: 33469811 [TBL] [Abstract][Full Text] [Related]
12. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases. Padmavathy F; Siddaraju N; Sistla SC Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095 [TBL] [Abstract][Full Text] [Related]
13. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Groisman GM; Amar M; Meir A Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination. Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041 [TBL] [Abstract][Full Text] [Related]
15. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma. Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440 [TBL] [Abstract][Full Text] [Related]
16. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Phillips RW; Frierson HF; Moskaluk CA Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477 [TBL] [Abstract][Full Text] [Related]
18. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. El-Zimaity HM; Graham DY Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Glickman JN; Chen YY; Wang HH; Antonioli DA; Odze RD Am J Surg Pathol; 2001 May; 25(5):569-78. PubMed ID: 11342767 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus. Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]